UpHealth Group (SGX:GRQ) EBITDA Margin %: 0.00% (As of Dec. 2025)


SGX:GRQ UpHealth Group Ltd SGX:GRQ
40 GF Score
Price S$0.16
! 3 Warning Signs
View Full Analysis

What is UpHealth Group EBITDA Margin %?

UpHealth Group SGX:GRQ 40 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates SGX:GRQ with a GF Score™ of 40/100. The stock has 3 warning signs investors should review. Among 665 Healthcare Providers & Services companies, UpHealth Group ranks worse than 150375.79% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. UpHealth Group's EBITDA for the six months ended in Dec. 2025 was S$-1.95 Mil. UpHealth Group's Revenue for the six months ended in Dec. 2025 was S$0.00 Mil. Therefore, UpHealth Group's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.


UpHealth Group  (SGX:GRQ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


UpHealth Group EBITDA Margin % Related Terms


UpHealth Group EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for UpHealth Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UpHealth Group EBITDA Margin % Chart

UpHealth Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.99 10.75 0.00 0.00 0.00

UpHealth Group Semi-Annual Data
Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SGX:GRQ vs HCA, THC, DVA: EBITDA Margin % Comparison

For the Medical Care Facilities subindustry, UpHealth Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UpHealth Group EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, UpHealth Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where UpHealth Group's EBITDA Margin % falls into.


SGX:GRQ
40GF Score
UpHealth Group Ltd SGX:GRQ
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UpHealth Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

UpHealth Group's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-6.423/0
= %

UpHealth Group's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.949/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
UpHealth Group (SGX:GRQ) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on UpHealth Group and its competitors. Over the past decade, UpHealth Group's EBITDA Margin % has ranged from 10.75 to 47.99. According to the industry distribution chart, UpHealth Group ranks #999999 out of 665 companies in the Healthcare Providers & Services industry.
Is UpHealth Group's EBITDA Margin % too high?
UpHealth Group's current EBITDA Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 10.75 to a high of 47.99. Based on the distribution chart, UpHealth Group ranks #999999 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, UpHealth Group has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does UpHealth Group's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, UpHealth Group ranks #999999 out of 665 companies for EBITDA Margin %. This places UpHealth Group in the lower half of its industry. The industry median EBITDA Margin % is 10.19. Historically, UpHealth Group's own EBITDA Margin % has ranged from 10.75 to 47.99 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.19, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on UpHealth Group and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UpHealth Group's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UpHealth Group stock overvalued right now?
UpHealth Group (SGX:GRQ) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. UpHealth Group's overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For UpHealth Group (SGX:GRQ), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

UpHealth Group Business Description

Address 8/1 Gostinichny P. Intra-City Area, Suite 506, Municipal District Marfino, Moscow, RUS, 127106
UpHealth Group Ltd, formerly known as Don Agro International Ltd, is an agricultural company in Russia engaged in the cultivation of agricultural crops and the production of raw milk. The segments of the company include the Crop segment, engaged in the production and sale of agricultural produce in the Russian Federation, mainly winter wheat, sunflower, and corn; and the Livestock segment which includes the breeding of dairy cows for milk production and the sale of livestock. The majority of the revenue is derived from the Crop segment. The company carries all its operations in Russia.
40GF Score

Get the complete analysis for SGX:GRQ

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.16
Price